GLP-1 Meds: Potential Breakthrough in Addiction Treatment [Bloomberg]

We’re excited to share promising news from the world of medical research that could benefit not only those looking to shed pounds but also individuals struggling with substance abuse disorders.

Recent studies have highlighted the potential of GLP-1 medications, like Ozempic, to aid in reducing alcohol consumption (see full article linked below).

A study led by Professor Christian Hendershot found that participants with alcohol use disorder who took semaglutide, the active ingredient in Ozempic, drank significantly less compared to those on a placebo (see full article linked below). This effect was noted to be stronger than any currently approved medications for alcoholism.

While these findings are preliminary and larger studies are needed for regulatory approval, they suggest that GLP-1s could be a game-changer for over 46 million Americans battling substance abuse disorders. These medications work by mimicking a hormone that suppresses appetite and cravings, which could explain the reduced consumption of alcohol and tobacco observed in users.

Our clinic is dedicated to providing the latest and most effective treatments for weight loss and overall health. We invite you to join us on this journey towards a healthier lifestyle, where cutting-edge science meets compassionate care. Join us today and take the first step towards a brighter, healthier future!

Original and Full Article: https://www.bloomberg.com/opinion/articles/2024-06-20/ozempic-can-treat-drug-alcohol-addiction-but-does-pharma-care?embedded-checkout=true

Reference: bloomberg.com